Corticosteroids, But Not TNF Antagonists, Are Associated With Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results From an International Registry

BACKGROUND AND AIMS: The impact of Coronavirus disease 2019 (COVID-19) on patients with inflammatory bowel disease (IBD) is unknown. We sought to characterize the clinical course of COVID-19 among patients with IBD and evaluate the association among demographics, clinical characteristics, and immuno...

Descripción completa

Detalles Bibliográficos
Autores principales: Brenner, Erica J., Ungaro, Ryan C., Gearry, Richard B., Kaplan, Gilaad G., Kissous-Hunt, Michele, Lewis, James D., Ng, Siew C., Rahier, Jean-Francois, Reinisch, Walter, Ruemmele, Frank M., Steinwurz, Flavio, Underwood, Fox E., Zhang, Xian, Colombel, Jean-Frederic, Kappelman, Michael D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: by the AGA Institute 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7233252/
https://www.ncbi.nlm.nih.gov/pubmed/32425234
http://dx.doi.org/10.1053/j.gastro.2020.05.032

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7233252/
https://www.ncbi.nlm.nih.gov/pubmed/32425234
http://dx.doi.org/10.1053/j.gastro.2020.05.032

Ejemplares similares